How small peptides block and reverse serpin polymerisation

Journal of Molecular Biology

Volumn 342, Issue 3, 2004, Pages 931-941

  Zhou, Aiwu ^a   Stein, Penelope E ^a   Huntington, James A ^a   Sivasothy, Pasupathy ^a   Lomas, David A ^a   Carrell, Robin W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

antithrombin; conformational diseases; peptides; polymerisation; serpins

Indexed keywords

PEPTIDE DERIVATIVE; SERINE PROTEINASE INHIBITOR; SYNTHETIC PEPTIDE; TETRAPEPTIDE; THREONINE;

ARTICLE; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; MOLECULAR INTERACTION; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE;

INSERTION SEQUENCES;

EID: 4444332086     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2004.07.078     Document Type: Article

References (40)

1. R.R. Kopito, and D. Ron Conformational disease Nature Cell Biol. 2 2000 E207 E209
2. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 81 2001 741 766
3. K.A. Conway, S.J. Lee, J.C. Rochet, T.T. Ding, R.E. Williamson, and P.T. Lansbury Jr Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy Proc. Natl Acad. Sci. USA 97 2000 571 576
4. S.B. Prusiner, M.R. Scott, S.J. DeArmond, and F.E. Cohen Prion protein biology Cell 93 1998 337 348
5. R.W. Carrell, and B. Gooptu Conformational changes and disease - serpins, prions and Alzheimer's Curr. Opin. Struct. Biol. 8 1998 799 809
6. R.W. Carrell, and D.A. Lomas Alpha1-antitrypsin deficiency-a model for conformational diseases N. Engl. J. Med. 346 2002 45 53
7. D.A. Lomas, and R.W. Carrell Human genetics and disease: serpinopathies and the conformational dementias Nature Rev. Genet. 3 2002 759 768
8. N.J. Beauchamp, R.N. Pike, M. Daly, L. Butler, M. Makris, and T.R. Dafforn Antithrombins Wibble and Wobble (T85M/K): archetypal conformational diseases with in vivo latent-transition, thrombosis, and heparin activation Blood 92 1998 2696 2706
9. 1-antitrypsin deficiency Scand. J. Clin. Lab. Invest. 15 1963 132 140
10. H.L. Sharp, R.A. Bridges, W. Krivit, and E.F. Freier Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognised inherited disorder J. Lab. Clin. Med. 73 1969 934 939
11. R.L. Davis, A.E. Shrimpton, P.D. Holohan, C. Bradshaw, D. Feiglin, and G.H. Collins Familial dementia caused by polymerization of mutant neuroserpin Nature 401 1999 376 379
12. 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function J. Mol. Biol. 177 1984 531 556
13. J.A. Huntington, R.J. Read, and R.W. Carrell Structure of a serpin-protease complex shows inhibition by deformation Nature 407 2000 923 926
14. 1-antitrypsin accumulation in the liver Nature 357 1992 605 607
15. J.A. Huntington, N.S. Pannu, B. Hazes, R.J. Read, D.A. Lomas, and R.W. Carrell A 2.6 A structure of a serpin polymer and implications for conformational disease J Mol. Biol. 293 1999 449 455
16. M.A. Dunstone, W. Dai, J.C. Whisstock, J. Rossjohn, R.N. Pike, and S.C. Feil Cleaved antitrypsin polymers at atomic resolution Protein Sci. 9 2000 417 420
17. A.J. Schulze, U. Baumann, S. Knof, E. Jaeger, R. Huber, and C.B. Laurell Structural transition of alpha 1-antitrypsin by a peptide sequentially similar to beta-strand s4A Eur. J. Biochem. 194 1990 51 56
18. H.L. Fitton, R.N. Pike, R.W. Carrell, and W.-S.W. Chang Mechanisms of antithrombin polymerisation and heparin activation probed by insertion of synthetic reactive loop peptides Biol. Chem. 378 1997 1059 1063
19. R. Mahadeva, T.R. Dafforn, R.W. Carrell, and D.A. Lomas 6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. Implications for the prevention of Z alpha(1)-antitrypsin- related cirrhosis J. Biol. Chem. 277 2002 6771 6774
20. Y. Xue, P. Bjorquist, T. Inghardt, M. Linschoten, D. Musil, L. Sjolin, and J. Deinum Interfering with the inhibitory mechanism of serpins: crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide Structure 6 1998 627 636
21. 1-proteinase inhibitor probed by limited proteolysis Biochemistry 31 1992 2720 2728
22. R. Skinner, W.S. Chang, L. Jin, X. Pei, J.A. Huntington, and J.P. Abrahams Implications for function and therapy of a 2.9 A structure of binary-complexed antithrombin J. Mol. Biol. 283 1998 9 14
23. L. Mourey, J.P. Samama, M. Delarue, M. Petitou, J. Choay, and D. Moras Crystal structure of cleaved bovine antithrombin III at 3.2 Å resolution J. Mol. Biol. 232 1993 223 241
24. R.W. Carrell, P.E. Stein, G. Fermi, and M.R. Wardell Biological implications of a 3 A structure of dimeric antithrombin Structure 2 1994 257 270
25. A. Zhou, P.E. Stein, J.A. Huntington, and R.W. Carrell Serpin polymerization is prevented by a hydrogen bond network that is centered on his-334 and stabilized by glycerol J. Biol. Chem. 278 2003 15116 15122
26. I. Bjork, K. Ylinenjarvi, S.T. Olson, and P.E. Bock Conversion of antithrombin from an inhibitor of thrombin to a substrate with reduced heparin affinity and enhanced conformational stability by binding of a tetradecapeptide corresponding to the P1 to P14 region of the putative reactive bond loop of the inhibitor J. Biol. Chem. 267 1992 1976 1982
27. W.S. Chang, J. Whisstock, P.C. Hopkins, A.M. Lesk, R.W. Carrell, and M.R. Wardell Importance of the release of strand 1C to the polymerization mechanism of inhibitory serpins Protein Sci. 6 1997 89 98
28. B. Gooptu, B. Hazes, W.S. Chang, T.R. Dafforn, R.W. Carrell, R.J. Read, and D.A. Lomas Inactive conformation of the serpin alpha(1)-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease Proc. Natl Acad. Sci. USA 97 2000 67 72
29. 1-antitrypsin Biochemistry 32 1993 500 508
30. L. Jin, J.P. Abrahams, R. Skinner, M. Petitou, R.N. Pike, and R.W. Carrell The anticoagulant activation of antithrombin by heparin Proc. Natl Acad. Sci. USA 94 1997 14683 14688
31. Leslie, A. W. G. (1992). Recent Changes to the MOSFLM Package for Processing Film and Image Data. In Joint CCP4 and ESF-EACMB Newsletter on Protein Crystallography, vol. 26. Daresbury Laboratory, Warrington, UK.
32. Evans, P. R. (1993). In Proceedings of the CCP4 Study Weekend. Data Collection and Processing (Sawyer, L., Isaacs, N., & Bailey, S.). vol. 114-122, Darsbury Laboratory, UK.
33. A.T. Brunger, P.D. Adams, G.M. Clore, W.L. DeLano, P. Gros, and R.W. Grosse-Kunstleve Crystallography and NMR system: A new software suite for macromolecular structure determination Acta Crystallog. sect. D 54 1998 905 921
34. N.S. Pannu, and R.J. Read Improved structure refinement throught maximum likelihood Acta Crystallog. sect. A 52 1996 659 668
35. T.A. Jones, J.-Y. Zou, S.W. Cowan, and M. Kjeldgaard Improved methods for building protein models in electron density maps and the location of errors in these models Acta Crystallog. sect. A 47 1991 110 119
36. P.J. Kraulis MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures J. Appl. Crystallog. 24 1991 946 950
37. R.M. Esnouf Further additions to MolScript version 1.4, including reading and contouring of electron-density maps Acta Crystallog. sect. D 55 1999 938 940
38. E.A. Merritt, and D.J. Bacon Raster3D: photorealistic molecular graphics Methods Enzymol. 277 1997 505 524
39. D.E. McRee XtalView/Xfit - a versatile program for manipulating atomic coordinates and electron density J. Struct. Biol. 125 1999 156 165
40. K. Diederichs, and A. Karplus Improved R-factors for diffraction data analysis in macromolecular crystallography Nature Struct. Biol. 4 1997 269 275